Dr Meghan McIlwain, Clinical Research Manager
President, The New Zealand Association of Clinical Research,
AUCKLAND, NEW ZEALAND
Bench Side Story continues with a Clinical Research Manager, and President of New Zealand Association of Clinical Research based in Auckland, NEW ZEALAND.
Dr Meghan McIlwain is a Clinical Research Manager, the President of the New Zealand Association of Clinical Research, a pharmacist and a guest lecturer at the University of Auckland School of Pharmacy. Through her career she’s been a hospital pharmacist, a community pharmacist, a postgraduate student, a postdoctoral researcher, a lecturer and an independent research consultant. Her PhD in is Pharmacy; specifically neuropsychopharmacology.
-
Respiratory health and the microbiome in the lung environment
Dr Taylor leads the Respiratory Health Group within the Microbiome and Host Health Program. His research employs tailored techniques that allow the lung environment to be characterised to a high level of accuracy, including detailed measurements of airway microbiology (microbiome), mucus composition, and inflammation. This information is used to identify predictive markers of chronic lung disease severity as well as determine effective forms of therapy.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
-
Anne O’Neill
STATE GOVERNMENT SUPPORTING MEDICAL RESEARCH
@ NSW HEALTH, NEW SOUTH WALES AUSTRALIA
